Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02626507
Title Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Eastchester Center for Cancer Care
Indications

Her2-receptor negative breast cancer

Therapies

Palbociclib

Gedatolisib

Goserelin

Fulvestrant

Age Groups: adult
Covered Countries USA


No variant requirements are available.